Scholars Central

Conference abstractPublished 20 Feb 2012

NMR metabolomics and drug discovery

Authors: Robert Powers

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Drug discovery is a complex and unpredictable endeavor with a high failure rate. Current trends in the pharmaceutical industry have exasperated these challenges and are contributing to the dramatic decline in productivity observed over the last decade. The industrialization of science by forcing the drug discovery process to adhere to assembly-line protocols is imposing unnecessary restrictions, such as short project time-lines. Our diseased-centered systems biology approach to drug discovery provides a unique infrastructure to identify novel druggable targets and therapeutic agents to increase the efficiency and success rate of drug discovery. One important component of our approach is the use and development of NMR-based metabolomics techniques to monitor the in vivo activity and selectivity of potential drugs. Similarly, NMR metabolomics can be used to monitor disease development, identify in vivo mechanisms of action for novel drugs, and evaluate mechanisms of drug resistance. Additionally, NMR metabolomics may be an invaluable approach to easily and rapidly diagnose human disease and assist in personalized medicine by monitoring a patient?s response to a particular treatment. Our NMR metabolomics technology, including our development of metabolomic tree diagrams and protocols for metabolite identification will be discussed. Also, our analysis of the mechanism of action and resistance of D-cycloserine (a TB drug), a metabolic signaling pathway for biofilm formation in S. aureus and S. epidermis , drug resistance in pancreatic cancer, and a potential diagnostic tool for multiple sclerosis will be presented.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Metabolomics:Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMetabolomics:Open Access
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Robert Powers”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels